opentargets-database

Name: opentargets-database
Availability: InStock
Author: robinbarvaag

Query the Open Targets Platform GraphQL API for target-disease associations and evidence.

Updated Jan 10, 2026

Search Tags:#drug discovery #genetics #target identification #opentargets #pharmacology #biomedical data

Ready to run

npx skills add https://github.com/robinbarvaag/poynt --skill opentargets-database-robinbarvaag

💬 Prompt for ChatGPT / Claude Chat▼

Please help me install this Agent Skill.
Skill: opentargets-database
Source: https://github.com/robinbarvaag/poynt/tree/main/.github/skills/opentargets-database
Command: npx skills add https://github.com/robinbarvaag/poynt --skill opentargets-database-robinbarvaag

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill requires requests, and includes scripts (resource) and references (resource) components.

What problem does it solve?

This Skill helps researchers and drug developers identify and prioritize potential therapeutic targets by querying the comprehensive Open Targets Platform, streamlining the drug discovery process.

Core Features & Use Cases

Target Identification: Find potential drug targets for specific diseases.
Evidence Gathering: Retrieve detailed genetic, clinical, and molecular evidence supporting target-disease links.
Drug Repurposing: Identify existing drugs that could be repurposed for new indications.
Use Case: A researcher wants to find new targets for Alzheimer's disease. They can use this Skill to search for genes associated with Alzheimer's, review the strength of evidence, and assess the druggability and safety of the top candidates.

Quick Start

Use the opentargets-database skill to find targets associated with Alzheimer's disease.

Frequently Asked Questions about opentargets-database

High-intent search queries and answers about installing and using this skill.

FAQPage Schema

How do I identify potential therapeutic targets for a specific disease?▼

You identify therapeutic targets by querying the Open Targets Platform API to retrieve target-disease associations and evaluate the supporting genetic, clinical, and molecular evidence. This streamlines drug discovery research.

How can I gather genetic and clinical evidence for drug repurposing?▼

Gathering genetic and clinical evidence for drug repurposing involves querying integrated biomedical datasets through the Open Targets API to retrieve detailed drug information and existing target-disease links. This validates new drug indications.

What is the best way to validate target-disease associations using biomedical data?▼

Validating target-disease associations is best achieved by querying the Open Targets Platform to analyze integrated biological and clinical datasets, retrieving detailed evidence to assess druggability and safety for drug discovery.

Do I need programmatic access to query the Open Targets Platform for pharmacology research?▼

Yes, you need programmatic access to query the Open Targets Platform GraphQL API. It requires the requests dependency to retrieve and analyze diverse biomedical data for pharmacology and target identification.

Can I assess the druggability and safety of drug targets for Alzheimer's disease?▼

You can assess the druggability and safety of targets for Alzheimer's disease by searching associated genes via the Open Targets API, reviewing the strength of genetic evidence, and evaluating the retrieved drug information.